These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8694153)

  • 1. What changes drug metabolism in critically ill patients--III? Effect of pre-existing disease on the metabolism of midazolam.
    Park GR; Miller E
    Anaesthesia; 1996 May; 51(5):431-4. PubMed ID: 8694153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What changes drug metabolism in critically ill patients?--II Serum inhibits the metabolism of midazolam in human microsomes.
    Park GR; Miller E; Navapurkar V
    Anaesthesia; 1996 Jan; 51(1):11-5. PubMed ID: 8669558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
    Gorski JC; Hall SD; Jones DR; VandenBranden M; Wrighton SA
    Biochem Pharmacol; 1994 Apr; 47(9):1643-53. PubMed ID: 8185679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
    Andersen V; Pedersen N; Larsen NE; Sonne J; Larsen S
    Br J Clin Pharmacol; 2002 Aug; 54(2):120-4. PubMed ID: 12207630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
    Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Hartwell PS; Raisys VA; Marsh CL; McVicar JP; Barr DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):549-56. PubMed ID: 7965755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
    Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Bacchi CE; Marsh CL; McVicar JP; Barr DM; Perkins JD
    J Pharmacol Exp Ther; 1994 Oct; 271(1):557-66. PubMed ID: 7965756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.
    Thummel KE; O'Shea D; Paine MF; Shen DD; Kunze KL; Perkins JD; Wilkinson GR
    Clin Pharmacol Ther; 1996 May; 59(5):491-502. PubMed ID: 8646820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
    Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
    Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.
    Mc Donnell CG; Shorten G; Van Pelt FN
    Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midazolam is metabolized by at least three different cytochrome P450 enzymes.
    Wandel C; Böcker R; Böhrer H; Browne A; Rügheimer E; Martin E
    Br J Anaesth; 1994 Nov; 73(5):658-61. PubMed ID: 7826796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.
    Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A
    Clin Pharmacol Ther; 1999 Aug; 66(2):110-7. PubMed ID: 10460064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal distribution of renal cytochrome P450 3A activity in humans.
    Haehner BD; Gorski JC; Vandenbranden M; Wrighton SA; Janardan SK; Watkins PB; Hall SD
    Mol Pharmacol; 1996 Jul; 50(1):52-9. PubMed ID: 8700118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1'-hydroxylation.
    Emoto C; Iwasaki K
    Xenobiotica; 2007 Jun; 37(6):592-603. PubMed ID: 17614006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients.
    Kirwan CJ; Lee T; Holt DW; Grounds RM; MacPhee IA; Philips BJ
    Intensive Care Med; 2009 Jul; 35(7):1271-5. PubMed ID: 19198803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
    Kronbach T; Mathys D; Umeno M; Gonzalez FJ; Meyer UA
    Mol Pharmacol; 1989 Jul; 36(1):89-96. PubMed ID: 2787473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral midazolam-grapefruit juice drug interaction.
    Goho C
    Pediatr Dent; 2001; 23(4):365-6. PubMed ID: 11572503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.